simplywall.st Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 435
- Sources here
- 19
- Companies here
- 21
Active search
435 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Modular Medical, Inc. Q1 FY2027: Net loss $(6.49M), EPS $(1.19) — 10-Q Summary
Modular Medical, Inc. (MODD) reported a net loss of $(6.49M) for Q1 FY2027, an improvement from the prior year, with diluted loss per share at $(1.19). The company's cash and cash equivalents significantly decreased, leading to a flagged going-concern risk due to liquidity issues. …
Why Immunovant (IMVT) Is Up 5.2% After Wider Q1 Loss, Moderna Cash, And Pivotal Data Hype
Immunovant (IMVT) saw its stock rise by 5.2% despite reporting a wider net loss in Q1 2026, reaching US$153.22 million. This positive market reaction is attributed to the anticipation of multiple upcoming pivotal data readouts for its IMVT-1402 drug and a significant upfront payment …
Solas Capital discloses 9.99% Modular Medical (MODD) position via stock and warrants
Solas Capital Management, LLC and Frederick Tucker Golden have reported an amended beneficial ownership of 9.99% in Modular Medical, Inc. (MODD). This stake comprises 552,171 shares, including common stock and shares issuable upon warrant exercise, with shared voting and dispositive power. The filing details …
Gentherm (THRM) lifts 2026 guidance and details Modine Performance Technologies combination
Gentherm (THRM) has raised its full-year 2026 guidance, expecting revenues between $1.55B and $1.65B and Adjusted EBITDA of $185M–$200M, while also detailing its proposed business combination with Modine Performance Technologies. This combination aims to expand Gentherm's product portfolio beyond light vehicles, into commercial vehicles, …
Modular Medical (MODD) investor group discloses 6.23% stake and warrant overhang
An investor group led by Bleichroeder LP has disclosed a 6.23% beneficial ownership stake in Modular Medical, Inc. (MODD), totaling 336,986 common shares with sole voting and dispositive power. The group also holds warrants for an additional 110,092 shares, but their exercise is subject …
Global Net Lease Completes Acquisition of Modiv Industrial
Global Net Lease, Inc. Adds a $535 Million Primarily Industrial Portfolio at Attractive Pricing of Approximately 7.6% Cash Cap Rate and 8.7% GAAP Cap Rate Expected to be Immediately 4% Accretive to AFFO Per Share in Leverage-Neutral Transaction Advances Portfolio Transformation with Increased Industrial …
Capital World Investors reports 5.6% Moderna (MRNA) stake in Schedule 13G filing
Capital World Investors, an investment management entity, has reported a 5.6% beneficial ownership stake in Moderna, Inc. (MRNA) through a Schedule 13G filing. This represents 22,276,996 shares out of 396,786,259 outstanding shares, with the firm holding sole voting power over 22,264,639 shares and sole …
Tema ETFs LLC Increases Stock Holdings in Modine Manufacturing Company $MOD
Tema ETFs LLC significantly increased its stake in Modine Manufacturing Company (NYSE:MOD) by 15.5% in the second quarter, bringing its total holdings to 113,679 shares valued at approximately $30.4 million. This move comes as Modine reported strong quarterly earnings, beating estimates, and a 28% …
Assenagon Asset Management S.A. Sells 18,626 Shares of Modine Manufacturing Company $MOD
Assenagon Asset Management S.A. has reduced its stake in Modine Manufacturing Company (NYSE:MOD) by 41.4%, selling 18,626 shares and retaining 26,379 shares valued at $7.04 million. Despite this reduction, institutional investors still hold 95.23% of the company's stock. Modine Manufacturing recently reported strong quarterly …
Asmodee Group AB (FRA:2EX) (Q1 2027) Earnings Call Highlights: Net Sales Surge 20. ...
This article first appeared on GuruFocus. Net Sales: EUR 422.1 million, up 20.9% (20.2% organically). Adjusted EBITDA: EUR 61.9 million, up 55%. Adjusted EBITDA Margin: 14.7%, up 330 basis points from 11.4% last year. Board Game Sales Growth: Up 16%. Trading Card Game Sales …